Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
The Journal.
00:00
Intro
This chapter explores the financial triumph of Ozempic and its impact on culture, alongside a look at the growth of its manufacturer, Novo Nordisk. It also addresses recent leadership issues that may affect the perception of the company's success.
Transcript
Play full episode
